General Cell Lines and Cell Cultures
Lonza Walkersville HUVEC – Human Umbilical Vein Endothelial Cells, Pooled, in EGM
Lonza's Cryopreserved HUVECs are shipped as frozen primaries. They are guaranteed to express CD31/105 and survive in culture through 15* population doublings (*except HUVEC-XL guaranteed through 5 PD).All cells test negative for mycoplasma, bacteria, yeast, and fungi. HIV-1, hepatitis B and hepatitis C are not detected for all donors and/or cell lots. A Certificate of Analysis is provided for each cell lot purchased.Benefits:Guaranteed through 15 population doublings Single or pooled donors available All cells test negative for mycoplasma, bacteria, yeast, and fungiHIV-1, Hepatitis B and Hepatitis C are not detected for all donors and/or cell lotsCertificate of Analysis provided for every cell lot Applications:Would healingAngiogenesisTissue engineeringInflammationOncologyPharmacologyVascular modelingTransfection Content:1 x Cryopreserved ampule HUVEC (pooled donor) containing ≥500,000 cells
Angio Proteomie GFP Expressing Human Umbilical Vein Endothelial Cells, Frozen Vial, >5x10^5 cells/vial, Passage 3, Puromycin resistant, Minimum Population Doubling Levels 18
GFP Expressing Human Umbilical Vein Endothelial Cells, Frozen Vial, >5x10^5 cells/vial, Passage 3, Puromycin resistant, Minimum Population Doubling Levels 18
ATCC NK-92; Natural Killer Cell; Human (Homo sapiens); NK-92 is a registered; trademark of Nantkwest, Inc
NK-92 cells are an interleukin-2 (IL-2) dependent natural killer cell line derived from peripheral blood mononuclear cells from a 50-year-old, White male with rapidly progressive non-Hodgkin's lymphoma. Use NK-92 cells in your cancer, immunology, and toxicology research.
Lonza Walkersville Human CD34+ Cell Nucleofector Kit
The Nucleofector 2b Device (or older generations I or II) works cell type specific kits, each of them dedicated to an individual primary cell. This Nucleofector Kit is the optimal kit for efficient transfection of primary human hematopoietic stem cells (CD34+) from cord blood or bone marrow.Benefits:High transfection efficiencies for primary cellsCells maintain functionality post transfectionApplications:Transfection of cell numbers in the range of 2 x 10⁵ to 2 x 10⁷ cells Low-throughput transfection in single cuvette formatContent:2.25 mL Nucleofector Solution for Human CD34+ Cells0.5 mL Supplement 130 µg pmaxGFP Vector (0.5 μg/μl in 10 mM Tris pH 8.0)25 Aluminum cuvette (100 µL)25 Single use pipettes
Agilent Technologies BL21-CODON PLUS RIPL CELLS
BL21-CodonPlus (DE3)-RIPL Competent Cells, 10 x 0.1mL, These cells contain extra copies of rare E. coli argU, ileY, leuW, proL tRNA genes which corrects for codon bias and dramatically improves expression of sequences from other organisms
ADDEXBIO TECHNOLOGIES BJAB Cells, Frozen Vial
Established from the inguinal tumor of an EBV-negative 5-year-old African girl with Burkitt lymphoma at the preterminal stage.
iQ Biosciences Wistar Rat PBMCs, 10M cells/vial
High-quality, high-viability (> 80%) peripheral blood mononuclear cells (PBMCs) from the Wistar rat, a widely-used outbred rat strain. Used for a wide variety of immunology-based applications, including in-vitro immunoassays and ex-vivo applications. All orders come with an iQ Certificate of Analysis.
HUMANCELLS BIOSCIENCES Naive Cynomolgus Peripheral Blood Mononuclear cells (Cynomolgus PBMCs) | Frozen | 10 million
Non-human Primates (NHP) are the closest phylogenic relatives to man. In biomedical research, they are often indispensable. Cynomolgus monkey (Macaca fascicularis) is a well-known NHP species widely used in various types of research, including toxicological, pharmacological, metabolic, physiological and psychological studies. These monkeys are originated from different areas of Southeast Asia and are now purpose-bred in a limited number of breeding centers in different geographical locations.
Sigma Aldrich Fine Chemicals Biosciences NEURONAL KELLY CELL LINE
NC3728136 NEURONAL KELLY CELL LINE
AllCells LLC Peripheral Blood, Cryopreserved, Mononuclear Cells (PBMC), 10M
Peripheral blood cells collected by apheresis are treated with ammonium chloride to remove red blood cells (RBCs) and washed to remove platelets. Viability is 90%. Our peripheral blood MNC products (PBMCs) are composed of, on average, 50% T cells, 20% monocytes, 10% B cells, 7% NK cells, and 3% granulocytes. Actual cell type percentages vary from collection to collection.